Results 161 to 170 of about 59,530 (191)
Rapid neurological recovery in Guillain-Barré syndrome treated with efgartigimod. [PDF]
Cheng Y +6 more
europepmc +1 more source
U1 Small Nuclear Ribonucleoprotein Autoantibodies Reflect the Disruption of the Blood-Nerve Barrier in Guillain-Barré Syndrome. [PDF]
Shimizu F +3 more
europepmc +1 more source
Guillain-Barré Syndrome: Progress in Diagnosis, Biomarkers, Neuroimaging and Management. [PDF]
Freiha J, Min YG, Osman C, Rajabally YA.
europepmc +1 more source
Guillain-Barré syndrome in the 100 years since its description by Guillain, Barré and Strohl.
In 1916, during the Battle of the Somme, Guillain, Barré and Strohl described two soldiers with severe generalised weakness and loss of sensation. Hughes et al .
Richard A C Hughes, Hugh John Willison
exaly +2 more sources
Guillain–Barré syndrome: Clinical variants and their pathogenesis
Numerous clinical subtypes of Guillain-Barré syndrome have been described over the century since the original description of the syndrome.
J B Winer
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Diagnosis dan Tatalaksana Guillain Barré Syndrome
Lombok Medical JournalGuillain-Barré Syndrome or GBS is one of the emergency conditions of neurology. Currently, its incidence is relatively low and rare, with a rate of 0.81 to 1.89 of 100,000 people in a year. Guillain-Barré Syndrome or GBS, also known as acute inflammatory demyelinating polyradiculoneuropathy, is a collection of clinical symptoms caused by an acute ...
null Grandis Cristagalli +6 more
openaire +1 more source
ASEAN Journal of Psychiatry
Abstract Introduction: Guillain Barré Syndrome (GBS), has been commonly seen as a paraneoplastic manifestation in patients of small cell lung cancer. However, few published case reports of GBS are seldom re-ported in non-small cell lung cancer patients worldwide.
Dr. Nirmal Raut +2 more
openaire +1 more source
Abstract Introduction: Guillain Barré Syndrome (GBS), has been commonly seen as a paraneoplastic manifestation in patients of small cell lung cancer. However, few published case reports of GBS are seldom re-ported in non-small cell lung cancer patients worldwide.
Dr. Nirmal Raut +2 more
openaire +1 more source

